SS Innovations International Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
SSII$2.11+11.1%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements
| March 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $948,152 | $2,022,276 |
| Restricted cash | 5,954,970 | 5,010,725 |
| Accounts receivable, net of allowances | 4,226,144 | 1,647,274 |
| Inventory | 6,162,235 | 6,327,256 |
| Prepaids and other current assets | 2,495,457 | 3,375,169 |
| Total Current Assets | 19,786,958 | 18,382,700 |
| Non-Current Assets: | ||
| Property, plant, and equipment, net | 2,061,596 | 790,164 |
| Right of use asset | 2,127,769 | 2,199,418 |
| Long Term Receivable | 5,659,347 | 2,640,342 |
| Loans & Advances (Related Party) | 1,409,555 | 1,466,462 |
| Total Non-Current Assets | 11,258,267 | 7,096,386 |
| Total Assets | $31,045,225 | $25,479,086 |
| LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY | ||
| Current Liabilities | ||
| Bank Overdraft Facility | $6,207,185 | 6,018,926 |
| Notes Payable | 2,450,000 | - |
| Right of use liability, current portion | 281,380 | 288,988 |
| Accounts payable | 1,446,218 | 900,903 |
| Deferred tax liability | 6,582 | 20,482 |
| Other accrued liabilities | 5,271,874 | 2,041,372 |
| Total Current Liabilities | 15,663,238 | 9,270,670 |
| NON-CURRENT LIABILITIES: | ||
| Right of use liability, non current portion | 1,846,389 | 1,910,432 |
| TOTAL NON-CURRENT LIABILITIES | 1,846,389 | 1,910,432 |
| TOTAL LIABILITIES | $17,509,627 | $11,181,102 |
| Commitments and contingencies | ||
| Stockholders’ (deficit) equity: | ||
| Common stock, 250,000,000 shares authorized, $0.0001 par value,170,739,381 shares and 170,711,881 shares issued and outstanding as of March 31, 2024, and December 31,2023 respectively | 17,073 | 17,071 |
| Preferred stock, $0.0001 par value per share; authorized 5,000,000 shares of Series A Non-Convertible Preferred Stock, 5000 shares and nil shares issued and outstanding as of March 31, 2024 and December 31, 2023 | 1 | 1 |
| Translation adjustment | (331,489) | (329,100) |
| Additional Paid in Capital | 51,077,789 | 49,039,341 |
| Accumulated other comprehensive income (loss) | 899,917 | 899,917 |
| Accumulated deficit | (38,127,694) | (35,329,246) |
| Total stockholders’ (deficit) equity | 13,535,597 | 14,297,984 |
| Total liabilities and stockholders’ (deficit) equity | $31,045,224 | $25,479,086 |
See accompanying notes to unaudited Condensed Consolidated Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.